Vasilis Vasiliou

Title: Vasilis Vasiliou: Innovator in Aldehyde Dehydrogenase Inhibitors

Introduction

Vasilis Vasiliou is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target aldehyde dehydrogenase enzymes. His work has implications for treating various cancers and inflammatory conditions.

Latest Patents

Vasilis Vasiliou holds a patent for "Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors." This patent describes compounds of Formula I, which may serve as effective aldehyde dehydrogenase inhibitors. The compounds are useful for treating a range of conditions, including various types of cancer and inflammation. The patent also includes methods for using these compounds and their pharmaceutically acceptable salts in therapeutic applications.

Career Highlights

Throughout his career, Vasilis has worked with prestigious institutions such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Yale University. His experience in these organizations has allowed him to contribute to significant advancements in medical research and drug development.

Collaborations

Vasilis has collaborated with esteemed colleagues, including Shyh Ming Yang and David Joseph Maloney. These partnerships have further enriched his research and innovation in the field of medicinal chemistry.

Conclusion

Vasilis Vasiliou's work in developing aldehyde dehydrogenase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various serious health conditions.